Clinicopathological features and outcomes of fibrolamellar hepatocellular carcinoma.

被引：0
|
作者：
Chakrabarti, Sakti
Kommalapati, Anuhya
Tella, Sri Harsha
Huffman, Brandon M.
Yadav, Siddhartha
Bin Riaz, Irbaz
Goyal, Gaurav
Borad, Mitesh J.
Mahipal, Amit
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Univ South Carolina, Columbia, SC 29208 USA
[3] Mayo Clin, Canc Ctr, Scottsdale, AZ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 04期
关键词：
D O I：
10.1200/JCO.2019.37.4_suppl.393
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
393
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Cytological features of fibrolamellar variant of hepatocellular carcinoma with review of literature
    Jain, M
    Niveditha, SR
    Bharadwaj, M
    Pathania, OP
    CYTOPATHOLOGY, 2002, 13 (03) : 179 - 182
  • [22] Methylome sequencing for fibrolamellar hepatocellular carcinoma depicts distinctive features
    Malouf, Gabriel G.
    Tahara, Tomomitsu
    Paradis, Valerie
    Fabre, Monique
    Guettier, Catherine
    Yamazaki, Jumpei
    Long, Hi
    Lu, Yue
    Raynal, Noel J-M
    Jelinek, Jaroslav
    Mouawad, Roger
    Khayat, David
    Brugieres, Laurence
    Raymond, Eric
    Issa, Jean-Pierre J.
    EPIGENETICS, 2015, 10 (09) : 872 - 881
  • [23] Nivolumab and lenvatanib combination for fibrolamellar carcinoma.
    Kent, Paul
    Schadde, Erik
    Fisher, Oliver M.
    Cornelius, Albert
    Estberg, Emma
    Ellison, Jessica
    Kim, Thomas
    Tasse, Jordan C.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [24] Managing fibrolamellar hepatocellular carcinoma
    Grandhi, Miral Sadaria
    Pawlik, Timothy M.
    EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (02): : 143 - 152
  • [25] FIBROLAMELLAR HEPATOCELLULAR-CARCINOMA
    FRIEDMAN, AC
    LICHTENSTEIN, JE
    GOODMAN, Z
    FISHMAN, EK
    SIEGELMAN, SS
    DACHMAN, AH
    RADIOLOGY, 1985, 157 (03) : 583 - 587
  • [26] Clinical features and surgical outcomes of fibrolamellar hepatocellular carcinoma: retrospective analysis of a single-center experience
    Anastasia Lemekhova
    Daniel Hornuss
    Georgios Polychronidis
    Philipp Mayer
    Christian Rupp
    Thomas Longerich
    Karl-Heinz Weiss
    Markus Büchler
    Arianeb Mehrabi
    Katrin Hoffmann
    World Journal of Surgical Oncology, 18
  • [27] Clinical features and surgical outcomes of fibrolamellar hepatocellular carcinoma: retrospective analysis of a single-center experience
    Lemekhova, Anastasia
    Hornuss, Daniel
    Polychronidis, Georgios
    Mayer, Philipp
    Rupp, Christian
    Longerich, Thomas
    Weiss, Karl-Heinz
    Buechler, Markus
    Mehrabi, Arianeb
    Hoffmann, Katrin
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2020, 18 (01)
  • [28] CLINICOPATHOLOGICAL FEATURES OF MALIGNANCY IN HEPATOCELLULAR-CARCINOMA
    TANAKA, J
    TOBE, T
    MORINO, T
    ARII, S
    MINEMATSU, S
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 23 : S96 - S100
  • [29] Management of fibrolamellar hepatocellular carcinoma
    Chaudhari, Vikram A.
    Khobragade, Krunal
    Bhandare, Manish
    Shrikhande, Shailesh V.
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (05)
  • [30] Biomarker for fibrolamellar hepatocellular carcinoma
    Benmaamar, Ramla
    LANCET ONCOLOGY, 2014, 15 (04): : E156 - E156
12345